When and why portal vein thrombosis matters in liver transplantation: A critical audit of 174 cases

Annals of Surgery

Volumn 259, Issue 4, 2014, Pages 760-766

  Hibi, Taizo ^a,b   Nishida, Seigo ^a,b   Levi, David M ^b   Selvaggi, Gennaro ^a,b   Tekin, Akin ^a,b   Fan, Ji ^a,b   Ruiz, Phillip ^a,c   Tzakis, Andreas G ^d  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c CAROLINAS MEDICAL CENTER   (United States)

^d DEPARTMENT OF COLORECTAL SURGERY   (United States)

Author keywords

Cavoportal hemitransposition; liver transplantation; mesoportal jump graft; portal vein thrombosis; renoportal anastomosis

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; ARTERIALIZATION; ARTICLE; CAVOPORTAL HEMITRANSPOSITION; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL HEMORRHAGE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER SURGERY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MIDDLE AGED; OVERALL SURVIVAL; PORTAL VEIN BLOOD FLOW; PORTAL VEIN THROMBOSIS; PORTORENAL SHUNT; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; THROMBECTOMY; THROMBOSIS; TREATMENT OUTCOME; VEIN GRAFT; VEIN RECONSTRUCTION;

ADULT; ANASTOMOSIS, SURGICAL; CASE-CONTROL STUDIES; END STAGE LIVER DISEASE; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; THROMBECTOMY; TREATMENT OUTCOME; VASCULAR GRAFTING; VENOUS THROMBOSIS;

EID: 84895928441     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000252     Document Type: Article

References (41)

1. Tzakis A, Todo S, Stieber A, et al. Venous jump grafts for liver transplantation in patients with portal vein thrombosis. Transplantation. 1989;48:530-531.
2. Tzakis AG, Kirkegaard P, Pinna AD, et al. Liver transplantation with cavoportal hemitransposition in the presence of diffuse portal vein thrombosis. Transplantation. 1998;65:619-624.
3. Sheil AG, Stephen MS, Chui AK, et al. A liver transplantation technique in a patient with a thrombosed portal vein and a functioning renal-lieno shunt. Clin Transplant. 1997;11:71-73.
4. Azoulay D, Hargreaves GM, Castaing D, et al. Caval inflow to the graft: A successful way to overcome diffuse portal system thrombosis in liver transplantation. J Am Coll Surg. 2000;190:493-496.
5. Kato T, Levi DM, DeFaria W, et al. Liver transplantation with renoportal anastomosis after distal splenorenal shunt. Arch Surg. 2000;135:1401-1404.
6. Erhard J, Lange R, Giebler R, et al. Arterialization of the portal vein in orthotopic and auxiliary liver transplantation. A report of three cases. Transplantation. 1995;60:877-879.
7. Yerdel MA, Gunson B, Mirza D, et al. Portal vein thrombosis in adults undergoing liver transplantation: Risk factors, screening, management, and outcome. Transplantation. 2000;69:1873-1881.
8. Llad'o L, Fabregat J, Castellote J, et al. Management of portal vein thrombosis in liver transplantation: Influence on morbidity and mortality. Clin Transplant. 2007;21:716-721.
9. Lendoire J, Raffin G, Cejas N, et al. Liver transplantation in adult patients with portal vein thrombosis: Risk factors, management and outcome. HPB (Oxford). 2007;9:352-356.
10. Vianna RM, Mangus RS, Kubal C, et al. Multivisceral transplantation for diffuse portomesenteric thrombosis. Ann Surg. 2012;255:1144-1150.
11. Selvaggi G, Weppler D, Nishida S, et al. Ten-year experience in porto-caval hemitransposition for liver transplantation in the presence of portal vein thrombosis. Am J Transplant. 2007;7:454-460.
12. Bhangui P, Lim C, Salloum C, et al. Caval inflow to the graft for liver transplantation in patientswith diffuse portal vein thrombosis: A 12-year experience. Ann Surg. 2011;254:1008-1016.
13. Ravaioli M, Zanello M, Grazi GL, et al. Portal vein thrombosis and liver transplantation: Evolution during 10 years of experience at the University of Bologna. Ann Surg. 2011;253:378-384.
14. Nikitin D, Jennings LW, Khan T, et al. Twenty years' follow-up of portal vein conduits in liver transplantation. Liver Transpl. 2009;15:400-406.
15. Tzakis A, Todo S, Starzl TE. Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg. 1989;210:649-652.
16. Nishida S, Nakamura N, Vaidya A, et al. Piggyback technique in adult orthotopic liver transplantation: An analysis of 1067 liver transplants at a single center. HPB (Oxford). 2006;8:182-188.
17. Dumortier J, Czyglik O, Poncet G, et al. Eversion thrombectomy for portal vein thrombosis during liver transplantation. Am J Transplant. 2002;2:934-938.
18. Molmenti EP, Roodhouse TW, Molmenti H, et al. Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation. Ann Surg. 2002;235:292-296.
19. Tzakis A, Todo S, Starzl TE. The anterior route for arterial graft conduits in liver transplantation. Transpl Int. 1989;2:121.
20. Nishida S, Kato T, Levi D, et al. Effect of protocol Doppler ultrasonography and urgent revascularization on early hepatic artery thrombosis after pediatric liver transplantation. Arch Surg. 2002;137:1279-1283.
21. Levey AS, Coresh J, Greene T, et al. Chronic Kidney Disease Epidemiology Collaboration. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53:766-772.
22. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847.
23. D'Agostino RB, Sr, Grundy S, Sullivan LM, et al. Validation of the Framingham coronary heart disease prediction scores: Results of a multiple ethnic groups investigation. JAMA. 2001;286:180-187.
24. Gaziano TA, Young CR, Fitzmaurice G, et al. Laboratory-based versus nonlaboratory-based method for assessment of cardiovascular disease risk: The NHANES I Follow-up Study cohort. Lancet. 2008;371:923-931.
25. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: The concept of a donor risk index. Am J Transplant. 2006;6:783-790.
26. Settmacher U, Stange B, Schaser KD, et al. Primary permanent arterialization of the portal vein in liver transplantation. Transpl Int. 2003;16:430-433.
27. Nivatvongs S, Sirijindakul B, Nontasoot B. Portal vein arterialization for liver transplantation with extensive portomesenteric vein thrombosis: A case report. Transplant Proc. 2004;36:2267-2268.
28. Ott R, Bohner C, Muller S, et al. Outcome of patients with pre-existing portal vein thrombosis undergoing arterialization of the portal vein during liver transplantation. Transpl Int. 2003;16:15-20.
29. Pokorny H, Langer F, Herkner H, et al. Influence of cumulative number of marginal donor criteria on primary organ dysfunction in liver recipients. Clin Transplant. 2005;19:532-536.
30. Chen H, Peng CH, Shen BY, et al. Multi-factor analysis of initial poor graft function after orthotopic liver transplantation. Hepatobiliary Pancreat Dis Int. 2007;6:141-146.
31. Katz SC, Shia J, Liau KH, et al. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg. 2009;249:617-623.
32. Englesbe MJ, Schaubel DE, Cai S, et al. Portal vein thrombosis and liver transplant survival benefit. Liver Transpl. 2010;16:999-1005.
33. Han G, Qi X, He C, et al. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. J Hepatol. 2011;54:78-88.
34. Perarnau JM, Baju A, D'alteroche L, et al. Feasibility and long-term evolution of TIPS in cirrhotic patients with portal thrombosis. Eur J Gastroenterol Hepatol. 2010;22:1093-1098.
35. Senzolo M, Tibbals J, Cholongitas E, et al. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther. 2006;23:767-775.
36. Luca A, Miraglia R, Caruso S, et al. Short-and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Gut. 2011;60:846-852.
37. Francoz C, Belghiti J, Vilgrain V, et al. Splanchnic vein thrombosis in candidates for liver transplantation: Usefulness of screening and anticoagulation. Gut. 2005;54:691-697.
38. Amitrano L, Guardascione MA, Menchise A, et al. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol. 2010;44: 448-451.
39. Senzolo M, Sartori MT, Lisman T. Should we give thromboprophylaxis to patients with liver cirrhosis and coagulopathy HPB (Oxford). 2009;11: 459-464.
40. Aucejo FN, Hashimoto K, Quintini C, et al. Triple-phase computed tomography and intraoperative flow measurements improve the management of portosystemic shunts during liver transplantation. Liver Transpl. 2008;14: 96-99.
41. Francoz C, Valla D, Durand F. Portal vein thrombosis, cirrhosis, and liver transplantation. J Hepatol. 2012;57:203-212.